These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10604564)

  • 41. Prolonged weakness after cisatracurium infusion: a case report.
    Davis NA; Rodgers JE; Gonzalez ER; Fowler AA
    Crit Care Med; 1998 Jul; 26(7):1290-2. PubMed ID: 9671384
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Failure to investigate anaesthetic anaphylaxis resulting in a preventable second anaphylactic reaction.
    Pedersen AF; Green S; Rose MA
    Anaesth Intensive Care; 2012 Nov; 40(6):1053-5. PubMed ID: 23194216
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Small trials and drug safety: when will we learn?
    Markovitz BP
    Pediatr Crit Care Med; 2003 Jan; 4(1):129. PubMed ID: 12656566
    [No Abstract]   [Full Text] [Related]  

  • 44. [The clinical pharmacology of cisatracurium].
    Mellinghoff H; Diefenbach C
    Anaesthesist; 1997 Jun; 46(6):481-5. PubMed ID: 9297378
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A comparison of the efficacy of cisatracurium and atracurium in kidney transplantation operation.
    Jirasiritham S; Tantivitayatan K; Jirasiritham S
    J Med Assoc Thai; 2004 Jan; 87(1):73-9. PubMed ID: 14971538
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anaphylaxis to neuromuscular blocking agents: cross-reactivity between rocuronium and cisatracurium.
    Molero Díez YB; Sanchis Dux R; Sánchez Tabernero Á; de Diego Fernández A
    Can J Anaesth; 2023 Feb; 70(2):286-287. PubMed ID: 36509951
    [No Abstract]   [Full Text] [Related]  

  • 47. Newer neuromuscular blocking agents: how do they compare with established agents?
    Sparr HJ; Beaufort TM; Fuchs-Buder T
    Drugs; 2001; 61(7):919-42. PubMed ID: 11434449
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Early skin and challenge testing after rocuronium anaphylaxis.
    Schulberg EM; Webb AR; Kolawole H
    Anaesth Intensive Care; 2016 May; 44(3):425-7. PubMed ID: 27246945
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Safety and quality of myoplegia in different types of abdominal surgeries].
    Mizikov VM; Deshko IuV; Stamov VI; Vinnitskiĭ LI
    Anesteziol Reanimatol; 2004; (5):47-9. PubMed ID: 15573725
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Newly developed muscle relaxants].
    Fukushima K
    Masui; 1997 Nov; 46 Suppl():S200-4. PubMed ID: 9508579
    [No Abstract]   [Full Text] [Related]  

  • 51. Cisatracurium besilate. A review of its pharmacology and clinical potential in anaesthetic practice.
    Bryson HM; Faulds D
    Drugs; 1997 May; 53(5):848-66. PubMed ID: 9129870
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tracheal intubating conditions and pharmacodynamics following cisatracurium in infants and children undergoing halothane and thiopental-fentanyl anesthesia.
    Meakin GH; Meretoja OA; Perkins RJ; Waite I; Taivainen T; Wirtavuori K; Murphy AK; Raiha L
    Paediatr Anaesth; 2007 Feb; 17(2):113-20. PubMed ID: 17238881
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The cerebral and cardiovascular effects of cisatracurium and atracurium in neurosurgical patients.
    Schramm WM; Papousek A; Michalek-Sauberer A; Czech T; Illievich U
    Anesth Analg; 1998 Jan; 86(1):123-7. PubMed ID: 9428865
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The pharmacodynamics of mivacurium preceded by atracurium or cisatracurium in children.
    Jalkanen L; Rautoma P; Taivainen T; Meretoja OA
    Anesth Analg; 1998 Jan; 86(1):62-5. PubMed ID: 9428852
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Anaphylactic/anaphylactoid reactions to anaesthetic and associated agents. Skin prick tests in aetiological diagnosis.
    Pepys J; Pepys EO; Baldo BA; Whitwam JG
    Anaesthesia; 1994 Jun; 49(6):470-5. PubMed ID: 8017588
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Does ester hydrolysis change the in vitro degradation rate of cisatracurium and atracurium?
    Weindlmayr-Goettel M; Gilly H; Kress HG
    Br J Anaesth; 2002 Apr; 88(4):555-62. PubMed ID: 12066733
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The clinical pharmacology of new benzylisoquinoline-diester compounds, with special consideration of cisatracurium and mivacurium].
    Savarese JJ; Lien CA; Belmont MR; Wastila WB
    Anaesthesist; 1997 Oct; 46(10):840-9. PubMed ID: 9424966
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A comparison of the neuromuscular blocking effects and reversibility of cisatracurium and atracurium.
    Carroll MT; Mirakhur RK; Lowry D; Glover P; Kerr CJ
    Anaesthesia; 1998 Aug; 53(8):744-8. PubMed ID: 9797517
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of 0.86 mg/kg cisatracurium in an infant.
    Brandom BW; Westman HR
    Anesthesiology; 1996 Sep; 85(3):688-9. PubMed ID: 8853107
    [No Abstract]   [Full Text] [Related]  

  • 60. Evaluation of cisatracurium, a new neuromuscular blocking agent, for tracheal intubation.
    Bluestein LS; Stinson LW; Lennon RL; Quessy SN; Wilson RM
    Can J Anaesth; 1996 Sep; 43(9):925-31. PubMed ID: 8874910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.